SERTAD1 and cancer: The poor prognosis has been seen in most of cancer patients, including brain, colon, lung, ovarian and skin cancer patients with higher SERTAD1 expression (Table 2 and Supplementary Figure S1) was in line with the obtained data from Kaplan-Meier plotter analysis (Figure 3).